Join our Free Newsletter and unlock 50% off AltIndexFree newsletter + 50% offJoin free
$51M 2.3%
Total revenue, Q2 '26 (USD).

Did Vanda Pharmaceuticals Beat Earnings?

Vanda Pharmaceuticals (VNDA) reported Q2 '26 revenue of $51M, down 3.9% year-over-year.

AltIndex tracks earnings alongside 25+ alternative data signals that can move ahead of the report — Vanda Pharmaceuticals’s job postings, web traffic, and employee business outlook. See the full VNDA stock analysis or the earnings calendar for upcoming reports.

Vanda Pharmaceuticals Quarterly Financial Trends (USD)

MetricQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26
Revenue48M53M50M53M56M57M52M51M
Gross margin94.6%95.1%93.0%91.5%94.7%93.3%90.0%93.0%
Operating margin-23.1%-19.3%-89.0%-73.2%-55.6%-70.5%-97.1%-126.3%
Net income-5.3M-4.9M-29M-27M-23M-141M-49M-63M
Net margin-11.2%-9.2%-58.9%-51.7%-40.1%-246.8%-93.9%-123.7%
EPS————————

Vanda Pharmaceuticals Earnings Trend Analysis

Over the eight quarters from Q3 '24 to Q2 '26, Vanda Pharmaceuticals’s quarterly revenue moved from $48M to $51M. Net margin compressed from -11.2% to -123.7%, against a 93% gross margin in the most recent quarter — a read on whether revenue growth is translating into profit.

When Is Vanda Pharmaceuticals’s Next Earnings Date?

Vanda Pharmaceuticals reports earnings on a quarterly schedule. Its most recent report covered Q2 '26. For the confirmed upcoming date — and every other company reporting soon — see the VNDA earnings calendar.

Frequently Asked Questions: Vanda Pharmaceuticals Earnings

Vanda Pharmaceuticals's next earnings date has not been confirmed yet. See the earnings calendar for all upcoming reports.

Vanda Pharmaceuticals reported Q2 '26 revenue of $51M, down 3.9% from the same quarter a year earlier.

Signals like job postings, web traffic, and employee sentiment reflect business activity in real time and can move before quarterly results are reported. AltIndex combines them with 25+ others in the VNDA AI Score.

The analytics provided are estimates and not a substitute for professional advice. All investments involve risks, including possible capital loss.